arrow
M

Michel C. Nussenzweig

Howard Hughes Medical Institute
H指数:183
被引数:11.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial

在HIV感染者男性接受分析性治疗中断期间的中和抗体:RIO试验II期随机对照试验的次要和探索性结局

2026-09-150
OAAI
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design

通过两步机制诱导广谱中和HIV抗体为疫苗设计提供信息

Science
IF45.8
2026-05-070
PRE
B lymphocyte protein factories produced by hematopoietic stem cell gene editing

造血干细胞基因编辑产生的B淋巴细胞蛋白质工厂

Science
IF45.8
2026-04-160
PRE
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control

自体中和抗体和多功能T细胞有助于长期HIV-1干预后控制

2026-03-030
OA
CD8+ T cell stemness precedes post-intervention control of HIV viremia

CD8+ T细胞干性先于干预后对HIV病毒血症的控制

Nature
IF48.5
2025-12-010
PRE
Correlates of HIV-1 control after combination immunotherapy

HIV-1控制与联合免疫治疗的相关因素

Nature
IF48.5
2025-12-010
PRE
Clonal expansion and diversification of germinal center and memory B cell responses to booster immunization in primates

灵长类动物中,生发中心克隆扩增和记忆B细胞对加强免疫接种的应答及其多样性

2025-08-120
OA
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses

墨西哥和巴西的人类抗体中和蜱传黄病毒

2024-06-010
OA
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV
2024-04-273
OAAI
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine
2024-01-031
OAAI
Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques
Science
IF45.8
2024-01-010
OA
Heteromultimeric sarbecovirus receptor binding domain immunogens primarily generate variant- specific neutralizing antibodies
2023-12-141
OAAI